De Leo E, Elmonem MA, Berlingerio SP, Berquez M, Festa BP, Raso R, Bellomo F, Starborg T, Janssen MJ, Abbaszadeh Z, Cairoli S, Goffredo BM, Masereeuw R, Devuyst O, Lowe M, Levtchenko E, Luciani A, Emma F, Rega LR (2020) Cell-based phenotypic drug screening identifies luteolin as candidate therapeutic for nephropathic cystinosis
Przeanalizujemy jego mechanizmy molekularne, wyniki bada klinicznych i przedklinicznych, potencjalne zastosowania, a take kwestie bezpieczestwa i regulacji
The peptide's extended half-life, marketed as a convenience feature (once-daily dosing), is the same property that drives systemic circulation and makes side effects unavoidable
The organization also notes that a sample of your blood may be used now or in the future for additional tests and other medical research with your consent
Chauhan, A., Audhya, T., & Chauhan, V
Qu bien corres, nadas, saltas 3 veces a la semana, no pierdes un gramo